Do analysts prefer SSKN or SDCCQ?

Given SmileDirectClub's higher possible upside, analysts clearly believe SmileDirectClub is more favorable than Strata Skin Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SmileDirectClub 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend GMVDF or SSKN?

Given G Medical Innovations' higher possible upside, equities research analysts plainly believe G Medical Innovations is more favorable than Strata Skin Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score G Medical Innovations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, GMVDF or SSKN?

Strata Skin Sciences has higher revenue and earnings than G Medical Innovations. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio G Medical Innovations $4.42M 0.00 -$24.63M N/A N/A Strata Skin Sciences $30.98M 0.00 -$10.09M -$1.41 N/A

Do analysts recommend TTOO or SSKN?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score T2 Biosystems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend VRAYQ or SSKN?

Given ViewRay's higher possible upside, analysts plainly believe ViewRay is more favorable than Strata Skin Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ViewRay 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, VRAYQ or SSKN?

Strata Skin Sciences has lower revenue, but higher earnings than ViewRay. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ViewRay $102.21M 0.00 -$107.33M N/A N/A Strata Skin Sciences $30.98M 0.00 -$10.09M -$1.41 N/A

Do analysts recommend SSKN or AFIB?

Given Acutus Medical's higher possible upside, analysts plainly believe Acutus Medical is more favorable than Strata Skin Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Acutus Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Strata Skin Sciences (SSKN) Competitors

$0.0050 0.00 (0.00%)

As of 09/22/2026 01:43 PM Eastern

Compare

SSKN vs. SDCCQ, GMVDF, TTOO, VRAYQ, and AFIB

Should you buy Strata Skin Sciences stock or one of its competitors? Strata Skin Sciences's main competitors and comparable companies include SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), T2 Biosystems (TTOO), ViewRay (VRAYQ), and Acutus Medical (AFIB). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Strata Skin Sciences compare to SmileDirectClub?

Strata Skin Sciences (NASDAQ:SSKN) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by insiders. Comparatively, 64.7% of SmileDirectClub shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Strata Skin Sciences' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company	Overall Sentiment
Strata Skin Sciences	Neutral
SmileDirectClub	Neutral

Strata Skin Sciences has higher earnings, but lower revenue than SmileDirectClub. Strata Skin Sciences is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Skin Sciences	$30.98M	0.00	-$10.09M	-$1.41	N/A
SmileDirectClub	$470.74M	0.00	-$86.40M	-$0.13	N/A

Given SmileDirectClub's higher possible upside, analysts clearly believe SmileDirectClub is more favorable than Strata Skin Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SmileDirectClub	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Strata Skin Sciences has a beta of 0.03, meaning that its stock price is 97% less volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.35, meaning that its stock price is 35% more volatile than the broader market.

SmileDirectClub has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. SmileDirectClub's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Skin Sciences	-35.64%	-476.73%	-33.49%
SmileDirectClub	N/A	N/A	N/A

Summary

SmileDirectClub beats Strata Skin Sciences on 9 of the 12 factors compared between the two stocks.

How does Strata Skin Sciences compare to G Medical Innovations?

G Medical Innovations (NASDAQ:GMVDF) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability.

6.0% of G Medical Innovations shares are held by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are held by institutional investors. 37.1% of G Medical Innovations shares are held by insiders. Comparatively, 40.9% of Strata Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

G Medical Innovations has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. G Medical Innovations' return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
G Medical Innovations	N/A	N/A	N/A
Strata Skin Sciences	-35.64%	-476.73%	-33.49%

Given G Medical Innovations' higher possible upside, equities research analysts plainly believe G Medical Innovations is more favorable than Strata Skin Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
G Medical Innovations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company	Overall Sentiment
G Medical Innovations	Neutral
Strata Skin Sciences	Neutral

G Medical Innovations has a beta of 28.66, suggesting that its stock price is 2,766% more volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of 0.03, suggesting that its stock price is 97% less volatile than the broader market.

Strata Skin Sciences has higher revenue and earnings than G Medical Innovations.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
G Medical Innovations	$4.42M	0.00	-$24.63M	N/A	N/A
Strata Skin Sciences	$30.98M	0.00	-$10.09M	-$1.41	N/A

Summary

G Medical Innovations and Strata Skin Sciences tied by winning 5 of the 10 factors compared between the two stocks.

How does Strata Skin Sciences compare to T2 Biosystems?

T2 Biosystems (NASDAQ:TTOO) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

Strata Skin Sciences has a net margin of -35.64% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
T2 Biosystems	-563.16%	N/A	-174.06%
Strata Skin Sciences	-35.64%	-476.73%	-33.49%

T2 Biosystems has a beta of 7.9, meaning that its share price is 690% more volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of 0.03, meaning that its share price is 97% less volatile than the broader market.

In the previous week, T2 Biosystems had 1 more articles in the media than Strata Skin Sciences. MarketBeat recorded 1 mentions for T2 Biosystems and 0 mentions for Strata Skin Sciences. T2 Biosystems' average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company	Overall Sentiment
T2 Biosystems	Neutral
Strata Skin Sciences	Neutral

Strata Skin Sciences has higher revenue and earnings than T2 Biosystems. Strata Skin Sciences is trading at a lower price-to-earnings ratio than T2 Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
T2 Biosystems	$7.68M	0.00	-$50.08M	-$3.89	N/A
Strata Skin Sciences	$30.98M	0.00	-$10.09M	-$1.41	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
T2 Biosystems	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

23.2% of T2 Biosystems shares are held by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are held by institutional investors. 0.0% of T2 Biosystems shares are held by company insiders. Comparatively, 40.9% of Strata Skin Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Strata Skin Sciences beats T2 Biosystems on 8 of the 13 factors compared between the two stocks.

How does Strata Skin Sciences compare to ViewRay?

ViewRay (NASDAQ:VRAYQ) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

15.5% of ViewRay shares are owned by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are owned by institutional investors. 2.5% of ViewRay shares are owned by insiders. Comparatively, 40.9% of Strata Skin Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, ViewRay's average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company	Overall Sentiment
ViewRay	Neutral
Strata Skin Sciences	Neutral

ViewRay has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of 0.03, meaning that its stock price is 97% less volatile than the broader market.

Given ViewRay's higher possible upside, analysts plainly believe ViewRay is more favorable than Strata Skin Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ViewRay	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Strata Skin Sciences has lower revenue, but higher earnings than ViewRay.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ViewRay	$102.21M	0.00	-$107.33M	N/A	N/A
Strata Skin Sciences	$30.98M	0.00	-$10.09M	-$1.41	N/A

ViewRay has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. ViewRay's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ViewRay	N/A	N/A	N/A
Strata Skin Sciences	-35.64%	-476.73%	-33.49%

Summary

ViewRay beats Strata Skin Sciences on 7 of the 11 factors compared between the two stocks.

How does Strata Skin Sciences compare to Acutus Medical?

Strata Skin Sciences (NASDAQ:SSKN) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

Given Acutus Medical's higher possible upside, analysts plainly believe Acutus Medical is more favorable than Strata Skin Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Acutus Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

32.4% of Strata Skin Sciences shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 40.9% of Strata Skin Sciences shares are owned by insiders. Comparatively, 5.2% of Acutus Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Strata Skin Sciences has a beta of 0.03, meaning that its share price is 97% less volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.73, meaning that its share price is 473% more volatile than the broader market.

Strata Skin Sciences has higher revenue and earnings than Acutus Medical. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Acutus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Skin Sciences	$30.98M	0.00	-$10.09M	-$1.41	N/A
Acutus Medical	$7.16M	0.00	-$81.66M	-$0.11	N/A

Strata Skin Sciences has a net margin of -35.64% compared to Acutus Medical's net margin of -272.74%. Acutus Medical's return on equity of -311.64% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Skin Sciences	-35.64%	-476.73%	-33.49%
Acutus Medical	-272.74%	-311.64%	-11.57%

In the previous week, Strata Skin Sciences' average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company	Overall Sentiment
Strata Skin Sciences	Neutral
Acutus Medical	Neutral

Summary

Acutus Medical beats Strata Skin Sciences on 7 of the 12 factors compared between the two stocks.

Get Strata Skin Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSKN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SSKN vs. The Competition

Export

Metric	Strata Skin Sciences	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$29K	$5.58B	$7.31B	$13.29B
Dividend Yield	N/A	1.79%	2.52%	12.57%
P/E Ratio	0.00	25.26	274.08	25.69
Price / Sales	0.00	71.56	638.21	78.99
Price / Cash	N/A	33.02	77.80	52.76
Price / Book	0.00	5.78	10.47	6.32
Net Income	-$10.09M	$151.55M	$3.49B	$359.73M
7 Day Performance	N/A	-0.01%	-0.67%	0.17%
1 Month Performance	N/A	-3.53%	-3.17%	-3.27%
1 Year Performance	N/A	6.37%	15.14%	5.58%

Strata Skin Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SSKN Strata Skin Sciences	N/A	$0.01 flat	N/A	-99.8%	$29K	$30.98M	N/A	114
SDCCQ SmileDirectClub	N/A	N/A	N/A	N/A	$40K	$470.74M	N/A	2,700	Gap Down
GMVDF G Medical Innovations	N/A	$0.00 flat	N/A	N/A	$26K	$4.42M	N/A	72
TTOO T2 Biosystems	N/A	$0.00 flat	N/A	-95.5%	$21K	$7.68M	N/A	180
VRAYQ ViewRay	N/A	N/A	N/A	N/A	$16K	$102.21M	N/A	300

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SSKN) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Strata Skin Sciences (SSKN) Competitors

SSKN vs. SDCCQ, GMVDF, TTOO, VRAYQ, and AFIB

How does Strata Skin Sciences compare to SmileDirectClub?

Summary

How does Strata Skin Sciences compare to G Medical Innovations?

Summary

How does Strata Skin Sciences compare to T2 Biosystems?

Summary

How does Strata Skin Sciences compare to ViewRay?

Summary

How does Strata Skin Sciences compare to Acutus Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSKN vs. The Competition

Strata Skin Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Strata Skin Sciences (SSKN) Competitors

SSKN vs. SDCCQ, GMVDF, TTOO, VRAYQ, and AFIB

How does Strata Skin Sciences compare to SmileDirectClub?

Do insiders & institutionals believe in SSKN or SDCCQ?

Does the media favor SSKN or SDCCQ?

Which has better earnings & valuation, SSKN or SDCCQ?

Do analysts prefer SSKN or SDCCQ?

Which has more volatility & risk, SSKN or SDCCQ?

Is SSKN or SDCCQ more profitable?

Summary

How does Strata Skin Sciences compare to G Medical Innovations?

Do insiders and institutionals hold more shares of GMVDF or SSKN?

Is GMVDF or SSKN more profitable?

Do analysts recommend GMVDF or SSKN?

Does the media refer more to GMVDF or SSKN?

Which has more volatility & risk, GMVDF or SSKN?

Which has preferable earnings and valuation, GMVDF or SSKN?

Summary

How does Strata Skin Sciences compare to T2 Biosystems?

Is TTOO or SSKN more profitable?

Which has more risk & volatility, TTOO or SSKN?

Does the media prefer TTOO or SSKN?

Which has better valuation & earnings, TTOO or SSKN?

Do analysts recommend TTOO or SSKN?

Do institutionals and insiders hold more shares of TTOO or SSKN?

Summary

How does Strata Skin Sciences compare to ViewRay?

Do institutionals & insiders believe in VRAYQ or SSKN?

Does the media prefer VRAYQ or SSKN?

Which has more risk and volatility, VRAYQ or SSKN?

Do analysts recommend VRAYQ or SSKN?

Which has preferable earnings & valuation, VRAYQ or SSKN?

Is VRAYQ or SSKN more profitable?

Summary

How does Strata Skin Sciences compare to Acutus Medical?

Do analysts recommend SSKN or AFIB?

Do insiders and institutionals hold more shares of SSKN or AFIB?

Which has more risk & volatility, SSKN or AFIB?

Which has better earnings & valuation, SSKN or AFIB?

Is SSKN or AFIB more profitable?

Does the media prefer SSKN or AFIB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSKN vs. The Competition

Strata Skin Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools